The tumor suppressive effects of aspirin involve several molecular mechanisms, and studies have shown that aspirin targets the COX-2 enzyme and inhibits COX2-mediated production of arachidonic acid-catalyzed prostaglandins (39). The gene discussed is PTGS2; the disease is neoplasm.